EMEA-001582-PIP01-13-M10 - paediatric investigation plan
Lumacaftor
ivacaftor
PIPHuman
Vertex Pharmaceuticals (Europe) Limited
Tel. +1 8776348789
E-mail: medicalinfo@vrtx.com
P/0506/2020: EMA decision of 22 December 2020 on the acceptance of a modification of an agreed paediatric investigation plan for lumacaftor / ivacaftor (Orkambi), (EMEA-001582-PIP01-13-M10)